P0042 - A case report of Benzylpiperazine induced new onset affective symptoms in a patient with schizophrenia

@article{Mohandas2008P0042A,
  title={P0042 - A case report of Benzylpiperazine induced new onset affective symptoms in a patient with schizophrenia},
  author={A. Mohandas and D. Vecchio},
  journal={European Psychiatry},
  year={2008},
  volume={23},
  pages={S315 - S316}
}
Background: We have noticed in our clinical practice a few patients with psychoses whose mental health was affected by the use of Benzylpiperazine related compounds. Benzylpiperazine and related compounds were sold legally in the UK until March 2007 when they were declared illegal. They are still legal in New Zealand whilst it is classified as a Class one drug along with LSD, cocaine and cannabis in the USA, Sweden, Denmark and Greece. Aims: To understand the effect of Benzylpiperazine based… Expand
Benzylpiperazine in New Zealand: brief history and current implications
Abstract Over the last decade, New Zealand has led the world in the legal sale and uncontrolled use of the recreational drug benzylpiperazine (BZP), the active ingredient of ‘party pills’. One surveyExpand
Update on 1-benzylpiperazine (BZP) party pills
TLDR
The in vivo and in vitro studies performed in order to understand its pharmacology, toxicology and kinetics are discussed and analytical methodologies for the identification of BZP in clinical and forensic settings are addressed. Expand
1-Benzylpiperazine and other Piperazine-based Derivatives
The piperazine derivatives include 1-benzylpiperazine (BZP), 1,3-trifluoromethylphenylpiperazine (TFMPP), 1-(3-chlorophenyl) piperazine (mCPP) and 1-(4-methoxyphenyl) piperazine (MeOPP); a fullExpand